Depression of ventilatory responses to hypoxia and hypercapnia after pentamorphone

M. S. Afifi, P. S A Glass, Norman Cohen, J. E. Shook, E. M. Camporesi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Pentamorphone is a novel, potent opiate with rapid onset and short duration of action that has been reported to produce analgesia with limited depression of ventilation. We quantified the effects of pentamorphone (0.08, 0.24, and 0.60 μg/kg, IV) on ventilatory responses to hypercapnia and hypoxia in 12 healthy volunteers. Normoxic hypercapnia and isocapnic hypoxia were induced through a rebreathing method. During each test we recorded ventilation (V̇E), end tidal carbon dioxide tension (PETCO2), and arterial oxygen saturation (SO2) using a pulse oximeter. Using linear regression analysis of the relationships between V̇E and PCO2 during hypercapnia and V̇E and SO2 during hypoxia, we determined the slope (slope CO2) and intercept (V̇55), both at PCO2 55 mm Hg, and the slope (slope O2) and intercept (V̇80) at SO2 80%. Pentamorphine produced dose-related reductions in the ventilatory responses to both hypercapnia and hypoxia. Maximal depression occurred 15 min after injection of pentamorphone with all doses; the highest dose (0.60 μg/kg) produced 48% and 53% reductions in slope CO2 and V̇55, and 42% and 22% reductions in slope O2 and V̇80, respectively, relative to parallel saline controls. The respiratory depressant actions of pentamorphone were short-lived, as all parameters returned to baseline levels within 45 min. Testing was continued for 180 min after injection, but not delayed ventilatory effects were detected, and minimal side effects were reported, even at the highest dose. The findings confirm previous reports that pentamorphine has limited ventilatory depressant effects in humans in doses that (in other studies) have been associated with clinically effective analgesia.

Original languageEnglish (US)
Pages (from-to)377-383
Number of pages7
JournalAnesthesia and Analgesia
Volume71
Issue number4
StatePublished - 1990
Externally publishedYes

Fingerprint

Hypercapnia
Respiratory Insufficiency
Ventilation
Analgesia
Opiate Alkaloids
Pulmonary Ventilation
Injections
Carbon Dioxide
Linear Models
Healthy Volunteers
Arterial Pressure
Regression Analysis
Oxygen
pentamorphone
Hypoxia

Keywords

  • Analgesics, pentamorphone
  • Ventilation, pentamorphone effects

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Afifi, M. S., Glass, P. S. A., Cohen, N., Shook, J. E., & Camporesi, E. M. (1990). Depression of ventilatory responses to hypoxia and hypercapnia after pentamorphone. Anesthesia and Analgesia, 71(4), 377-383.

Depression of ventilatory responses to hypoxia and hypercapnia after pentamorphone. / Afifi, M. S.; Glass, P. S A; Cohen, Norman; Shook, J. E.; Camporesi, E. M.

In: Anesthesia and Analgesia, Vol. 71, No. 4, 1990, p. 377-383.

Research output: Contribution to journalArticle

Afifi, MS, Glass, PSA, Cohen, N, Shook, JE & Camporesi, EM 1990, 'Depression of ventilatory responses to hypoxia and hypercapnia after pentamorphone', Anesthesia and Analgesia, vol. 71, no. 4, pp. 377-383.
Afifi, M. S. ; Glass, P. S A ; Cohen, Norman ; Shook, J. E. ; Camporesi, E. M. / Depression of ventilatory responses to hypoxia and hypercapnia after pentamorphone. In: Anesthesia and Analgesia. 1990 ; Vol. 71, No. 4. pp. 377-383.
@article{b0a525e7caf74240b3398b54e90a552b,
title = "Depression of ventilatory responses to hypoxia and hypercapnia after pentamorphone",
abstract = "Pentamorphone is a novel, potent opiate with rapid onset and short duration of action that has been reported to produce analgesia with limited depression of ventilation. We quantified the effects of pentamorphone (0.08, 0.24, and 0.60 μg/kg, IV) on ventilatory responses to hypercapnia and hypoxia in 12 healthy volunteers. Normoxic hypercapnia and isocapnic hypoxia were induced through a rebreathing method. During each test we recorded ventilation (V̇E), end tidal carbon dioxide tension (PETCO2), and arterial oxygen saturation (SO2) using a pulse oximeter. Using linear regression analysis of the relationships between V̇E and PCO2 during hypercapnia and V̇E and SO2 during hypoxia, we determined the slope (slope CO2) and intercept (V̇55), both at PCO2 55 mm Hg, and the slope (slope O2) and intercept (V̇80) at SO2 80{\%}. Pentamorphine produced dose-related reductions in the ventilatory responses to both hypercapnia and hypoxia. Maximal depression occurred 15 min after injection of pentamorphone with all doses; the highest dose (0.60 μg/kg) produced 48{\%} and 53{\%} reductions in slope CO2 and V̇55, and 42{\%} and 22{\%} reductions in slope O2 and V̇80, respectively, relative to parallel saline controls. The respiratory depressant actions of pentamorphone were short-lived, as all parameters returned to baseline levels within 45 min. Testing was continued for 180 min after injection, but not delayed ventilatory effects were detected, and minimal side effects were reported, even at the highest dose. The findings confirm previous reports that pentamorphine has limited ventilatory depressant effects in humans in doses that (in other studies) have been associated with clinically effective analgesia.",
keywords = "Analgesics, pentamorphone, Ventilation, pentamorphone effects",
author = "Afifi, {M. S.} and Glass, {P. S A} and Norman Cohen and Shook, {J. E.} and Camporesi, {E. M.}",
year = "1990",
language = "English (US)",
volume = "71",
pages = "377--383",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Depression of ventilatory responses to hypoxia and hypercapnia after pentamorphone

AU - Afifi, M. S.

AU - Glass, P. S A

AU - Cohen, Norman

AU - Shook, J. E.

AU - Camporesi, E. M.

PY - 1990

Y1 - 1990

N2 - Pentamorphone is a novel, potent opiate with rapid onset and short duration of action that has been reported to produce analgesia with limited depression of ventilation. We quantified the effects of pentamorphone (0.08, 0.24, and 0.60 μg/kg, IV) on ventilatory responses to hypercapnia and hypoxia in 12 healthy volunteers. Normoxic hypercapnia and isocapnic hypoxia were induced through a rebreathing method. During each test we recorded ventilation (V̇E), end tidal carbon dioxide tension (PETCO2), and arterial oxygen saturation (SO2) using a pulse oximeter. Using linear regression analysis of the relationships between V̇E and PCO2 during hypercapnia and V̇E and SO2 during hypoxia, we determined the slope (slope CO2) and intercept (V̇55), both at PCO2 55 mm Hg, and the slope (slope O2) and intercept (V̇80) at SO2 80%. Pentamorphine produced dose-related reductions in the ventilatory responses to both hypercapnia and hypoxia. Maximal depression occurred 15 min after injection of pentamorphone with all doses; the highest dose (0.60 μg/kg) produced 48% and 53% reductions in slope CO2 and V̇55, and 42% and 22% reductions in slope O2 and V̇80, respectively, relative to parallel saline controls. The respiratory depressant actions of pentamorphone were short-lived, as all parameters returned to baseline levels within 45 min. Testing was continued for 180 min after injection, but not delayed ventilatory effects were detected, and minimal side effects were reported, even at the highest dose. The findings confirm previous reports that pentamorphine has limited ventilatory depressant effects in humans in doses that (in other studies) have been associated with clinically effective analgesia.

AB - Pentamorphone is a novel, potent opiate with rapid onset and short duration of action that has been reported to produce analgesia with limited depression of ventilation. We quantified the effects of pentamorphone (0.08, 0.24, and 0.60 μg/kg, IV) on ventilatory responses to hypercapnia and hypoxia in 12 healthy volunteers. Normoxic hypercapnia and isocapnic hypoxia were induced through a rebreathing method. During each test we recorded ventilation (V̇E), end tidal carbon dioxide tension (PETCO2), and arterial oxygen saturation (SO2) using a pulse oximeter. Using linear regression analysis of the relationships between V̇E and PCO2 during hypercapnia and V̇E and SO2 during hypoxia, we determined the slope (slope CO2) and intercept (V̇55), both at PCO2 55 mm Hg, and the slope (slope O2) and intercept (V̇80) at SO2 80%. Pentamorphine produced dose-related reductions in the ventilatory responses to both hypercapnia and hypoxia. Maximal depression occurred 15 min after injection of pentamorphone with all doses; the highest dose (0.60 μg/kg) produced 48% and 53% reductions in slope CO2 and V̇55, and 42% and 22% reductions in slope O2 and V̇80, respectively, relative to parallel saline controls. The respiratory depressant actions of pentamorphone were short-lived, as all parameters returned to baseline levels within 45 min. Testing was continued for 180 min after injection, but not delayed ventilatory effects were detected, and minimal side effects were reported, even at the highest dose. The findings confirm previous reports that pentamorphine has limited ventilatory depressant effects in humans in doses that (in other studies) have been associated with clinically effective analgesia.

KW - Analgesics, pentamorphone

KW - Ventilation, pentamorphone effects

UR - http://www.scopus.com/inward/record.url?scp=0025200685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025200685&partnerID=8YFLogxK

M3 - Article

C2 - 1698039

AN - SCOPUS:0025200685

VL - 71

SP - 377

EP - 383

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 4

ER -